Kristen Mahoney Shannon, MS, CGC, is a Professor in the School of Health and Rehabilitation Sciences and professor and advisory board member in the Master of Science in Genetic Counseling program at MGH Institute of Health Professions. Ms. Shannon has worked as a clinical genetic counselor for over 20 years, specializing in oncology genetics services. In her current role, she serves as Director of the Massachusetts General Hospital Cancer Center’s Genetics Program and the Director of Genetic Counseling in the Massachusetts General Hospital's Department of Medicine.
Ms. Shannon played an instrumental role in the establishment of licensure for genetic counselors in the state of Massachusetts and has served on the Massachusetts Genetic Counselor Licensure board in various roles. She has served on multiple committees, subcommittees, and working groups of the National Society of Genetic Counselors. She is an active member of the NCCN Genetic Familial High-Risk Assessment: Breast and Ovarian Panel as well as the American Society of Clinical Oncology PLWC Advisory Board.
- BA, Biology, College of the Holy Cross, Worcester, MA
- MS, Human Genetics, Sarah Lawrence College, Bronxville, NY
Research Interests
Ms. Shannon’s research interests include genetic counseling and testing in the oncology setting, service delivery models within cancer genetic testing, and genetic counseling outcomes.
Ms. Shannon has lectured and published widely in the fields of cancer genetics and cancer genetic counseling and is a co-author of the March 2023 book, Counseling About Cancer: Strategies for Genetic Counseling.
--
Farmer MB, Bonadies DC, Pederson HJ, Mraz KA, Whatley JW, Darnes DR, Denton JJ, De Rosa D, Heatherly A, Kenney J, Lane K, Paul D, Pelletier RC, Shannon KM, Williams D, Matloff ET. Challengers and Errors in Genetic Testing: The Fifth Case Series. Cancer J 2021; 27:417-422.
McDuff SGR, Bellon JR, Shannon KM, Gadd MA, Dunn S, Rosenstein BS, Ho AY. ATM Variants in Breast Cancer: Implications for Breast Radiotherapy Treatment Recommendations.Int J Radiat Oncol Biol Phys. 2021 Feb 2;. doi: 10.1016/j.ijrobp.2021.01.045.
Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML, Karlan BY, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G, Senter-Jamieson L, Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102.
Shannon KM, Emmet MM, Rodgers LH, Wooters M, Seidel ML. Transition to telephone genetic counseling services during the COVID-19 pandemic.J Genet Couns. 2020 Dec 4;. doi: 10.1002/jgc4.1365. [Epub ahead of print]
Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pal T, Pederson HJ, Reiser G, Shannon KM, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Dwyer MA, Darlow SD. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.J Natl Compr Canc Netw. 2020
Isakoff, SJ, Lehman, CD, Shannon, KM, Basnet, KM. Case 7-2020: A 52-Year-Old Man with a Mass in the Left Breast. N Engl J Med, 2020;382:856-64.
Alimena S, Scarpetti L, Blouch EL, Rodgers L, Shannon KM, delCarmen MG, Goodman AK, Growdon W, Eisenhauer EL, Sisodia RC. Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer. International Journal of Gynecologic Cancer Published Online First: 23 May 2020. doi: 10.1136/ijgc-2019-001168